Evidence map›Paper›PMID 25270690›Full record

ArticleGenetic epidemiology2014

Functional-mixed effects models for candidate genetic mapping in imaging genetic studies.

Ja-An Lin, Hongtu Zhu, Ahn Mihye, Wei Sun, Joseph G Ibrahim, Alzheimer's Neuroimaging Initiative

Open access · greenAbstract read
In one paragraph

Article in Genetic epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Simultaneous Covariance Inference for Multimodal Integrative Analysis.Journal of the American Statistical Association · 2020
    Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ja-An LinDepartment of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Hongtu Zhu
Ahn Mihye
Wei Sun
Joseph G Ibrahim
Alzheimer's Neuroimaging Initiative
University of North Carolina at Chapel Hill · USAlzheimer’s Disease Neuroimaging Initiative · US

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI JIN, LEE-WAY · 1991 to 2020
$28.3M
Statistical Methods for Cancer Clinical TrialsP01CA142538 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TSIATIS, ANASTASIOS A · 2010 to 2019
$21.3M
TISSUE PROCUREMENT &ANALYSISP50CA106991 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TEPPER, JOEL E · 2004 to 2009
$12.1M
The System of Response to DNA Damage Suppresses Environmental MelanomagenesisP01ES014635 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHIELDS, JANIEL M · 2007 to 2011
$6.7M
Biostatistics for Research in Genomics and CancerT32CA106209 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOSEPH G IBRAHIM, Naim Ur Rashid · 2004 to 2026
$4.8M
Statistical Methods for RNA-seq Data AnalysisR01GM105785 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Wei Sun · 2014 to 2026
$4.6M
Statistical Analysis of Biomedical Imaging Data in Curved SpaceR01MH086633 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI IBRAHIM, JOSEPH G · 2010 to 2018
$2.9M
"MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies"K01AG030514 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARMICHAEL, OWEN T. · 2008 to 2012
$495k
NCI NIH HHS CA167684-02NCI NIH HHS P01 CA142538NCI NIH HHS P01CA142538-01NCI NIH HHS P50 CA106991NCI NIH HHS R01 CA070101NCI NIH HHS R03 CA167684NCI NIH HHS T32 CA106209NCRR NIH HHS RR025747-01NIA NIH HHS K01 AG030514NIA NIH HHS P30 AG010129NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG024904NIEHS NIH HHS P01 ES014635NIEHS NIH HHS P30 ES010126NIGMS NIH HHS GM105785-01NIGMS NIH HHS R01 GM105785NIMH NIH HHS MH086633NIMH NIH HHS R01 MH086633
6 · The paper itself

Abstract

The aim of this paper is to develop a functional-mixed effects modeling (FMEM) framework for the joint analysis of high-dimensional imaging data in a large number of locations (called voxels) of a three-dimensional volume with a set of genetic markers and clinical covariates. Our FMEM is extremely useful for efficiently carrying out the candidate gene approaches in imaging genetic studies. FMEM consists of two novel components including a mixed effects model for modeling nonlinear genetic effects on imaging phenotypes by introducing the genetic random effects at each voxel and a jumping surface model for modeling the variance components of the genetic random effects and fixed effects as piecewise smooth functions of the voxels. Moreover, FMEM naturally accommodates the correlation structure of the genetic markers at each voxel, while the jumping surface model explicitly incorporates the intrinsically spatial smoothness of the imaging data. We propose a novel two-stage adaptive smoothing procedure to spatially estimate the piecewise smooth functions, particularly the irregular functional genetic variance components, while preserving their edges among different piecewise-smooth regions. We develop weighted likelihood ratio tests and derive their exact approximations to test the effect of the genetic markers across voxels. Simulation studies show that FMEM significantly outperforms voxel-wise approaches in terms of higher sensitivity and specificity to identify regions of interest for carrying out candidate genetic mapping in imaging genetic studies. Finally, FMEM is used to identify brain regions affected by three candidate genes including CR1, CD2AP, and PICALM, thereby hoping to shed light on the pathological interactions between these candidate genes and brain structure and function.

Indexed as

Models, GeneticAlgorithmsBrainGenetic MarkersHumansLikelihood FunctionsGenetic Markersadaptive smoothingcandidate genetic mappingfunctional-mixed effects modelsjumping surface modellikelihood ratio statisticvariance components

Identifiers

PMID25270690
PMCPMC4236266
OpenAlexW1982390374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.